Aegis: Thymosin Alpha 1 3.2mg | Thymalin 2.5mg | Ursolic Acid 25mg | RG3 Ginsenoside 50mg | AMPK Activator 50mg

Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

What is Aegis Thymosin Alpha 1 Complex?

This peptide formulation combines thymic peptides with metabolic and immunomodulatory compounds: Thymosin Alpha 1, Thymalin, Ursolic Acid, RG3 Ginsenoside, and an AMPK Activator. Together, these agents synergize across immune restoration, anti-inflammation, metabolic regulation, anti-cancer activity, and antisenescence pathways.

Aegis Thymosin Alpha 1 3.2mg | Thymalin 2.5mg | Ursolic Acid 25mg | RG3 Ginsenoside 50mg | AMPK Activator 50mg

EXTENDED PROTOCOL

Thymosin Alpha 1:

Stimulates CD4+/CD8+ T-cell differentiation and Th1 immunity. Enhances dendritic cell function and MHC class I expression, suppresses NF-κB and chronic inflammation.

Thymalin:

Regulates gene expression via chromatin remodeling. Normalizes immune cell populations and rejuvenates thymic activity. Anti-senescence via telomerase support and inflammatory downregulation.

Ursolic Acid:

Activates AMPK, enhances mitochondrial function and fat oxidation. Inhibits NF-κB and STAT3 signaling (anti-inflammatory, anti-cancer). Reduces muscle wasting and supports metabolic regeneration.

RG3 Ginsenoside:

Inhibits NF-κB and COX-2 (inflammatory suppression). Blocks VEGF and MMP pathways to reduce tumor angiogenesis. Activates Nrf2 antioxidant defense and induces apoptosis in damaged cells.

AMPK Activator:

Increases PGC-1α and mitochondrial biogenesis. Induces autophagy via ULK1 activation. Suppresses mTOR and NF-κB (aging and inflammation dampening).

Clinical Applications:

Immune Restoration – Post-viral fatigue, immune suppression, and immunosenescence recovery.
Autoimmune Balancing – Normalizes overactive immune responses and reduces chronic inflammation.
Senescence Reversal / Longevity Protocols – Supports telomerase activity and reduces aging markers.
Metabolic & Fat Loss Support – Enhances fat oxidation and improves insulin sensitivity.
Muscle Maintenance & Recovery – Prevents muscle wasting during illness or aging.
Oncology Support (Adjunctive Use) – Reduces tumor angiogenesis and induces apoptosis in damaged cells.

Testimonies

Promising Clinical Advances

Our clinical trials with Cellgenic Lyophilized Exosomes have shown promising results in orthopedic regenerative therapies.

John Carter

Regenerative Medicine Researcher

Improved Outcomes

Patients report less pain and increased functionality post-treatment, which is a big win in physical therapy.

Kathie Corl

Rehabilitation Specialist

Faster and Stronger Returns

I’ve been using Cellgenic Lyophilized Exosomes for my athletes suffering from ligament injuries. The recovery process has not only sped up but also strengthened the tissues around the injuries.

John Carter

Sports Medicine Doctor

Quicker Healing Post-Surgery

After integrating Cellgenic Lyophilized Exosomes into our post-surgical recovery protocols, we’ve observed significantly improved healing times and reduced inflammation in our patients.

Kathie Corl

Orthopedic Surgeon

Frequently asked questions

Gain insights on the uses, benefits, and guidelines for Cellgenic Lyophilized Exosomes Orthopedics

Cellgenic’s cellular products aim to provide various biological effects, including anti-inflammatory, regenerative, and immunomodulatory properties. These benefits are intended to assist in the recovery and improvement of various medical conditions.

Cellgenic’s products are designed for medical professionals only, including licensed physicians and healthcare institutions. These products must be administered by individuals who are trained and authorized to use cellular therapies.

Packages vary depending on the specific product but generally include the cellular product in a suitable formulation, along with necessary diluents or other components required for the application of the therapy.

These products work by promoting cell-to-cell communication, enhancing cellular functions, and providing necessary growth factors, cytokines, and other bioactive molecules to support tissue repair and regeneration.

Yes, interested buyers must have their account verified and activated by Cellgenic. This process includes confirming the credentials of the healthcare professionals and ensuring compliance with applicable regulations before purchases can be made.